A European perspective-comments on "infantile spasms: A U.S. consensus report"

Epilepsia

Volumn 51, Issue 10, 2010, Pages 2215-2216

  Riikonen, Raili ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; LAMOTRIGINE; NITRAZEPAM; PREDNISOLONE; PYRIDOXINE; SOMATOMEDIN C; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

4 AMINOBUTYRIC ACID BRAIN LEVEL; APOPTOSIS; BASAL GANGLION; BRAIN DEGENERATION; BRAIN STEM; COGNITION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DYSKINESIA; EARLY LIFE STRESS; ELECTROENCEPHALOGRAM; EUROPE; HUMAN; INFANTILE SPASM; LOW DRUG DOSE; NEUROSURGERY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSYCHOMOTOR RETARDATION; RELAPSE; SIDE EFFECT; THALAMUS; TREATMENT DURATION; TREATMENT RESPONSE; TUBEROUS SCLEROSIS; UNITED STATES; UNSPECIFIED SIDE EFFECT; VISUAL FIELD DEFECT;

ADRENOCORTICOTROPIC HORMONE; CONSENSUS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; CROSS-CULTURAL COMPARISON; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; EUROPE; HUMANS; INFANT; SPASMS, INFANTILE; UNITED STATES; VIGABATRIN;

EID: 78649263434     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02704.x     Document Type: Note

References (19)

1. A working group appointed by the Finnish Medical Society Duodecim and the Finnish Association of Pediatric Neurology. Childhood epilepsy and febrile seizures. Current care guideline, Helsinki, Finland [In Finnish].
2. Baram T, Michell W, Tornay A, Snead O III, Hanson R, Horton E,. (1996) High-dose corticotrophin (ACTH) versus prednisolone for infantile spasms. Pediatrics 97: 375-379.
3. Bittigau P, Sifringer R, Ikonomidu C,. (2003) Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci 993: 103-114.
4. Darke K, Edwards S, Hancock E, Johnson A, Kennedy C, Lux A, Newton R, O'Callaghan F, Verity C, Osborne J,; trial steering committee on behalf of participating investigators. (2010) Developmental and epilepsy outcomes at ages 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomized trial. Arch Dis Child 95: 382-386.
5. Elterman R, Shields W, Mansfield K, Nakagawa J,; the US Infantile Spasms Vigabatrin Group. (2001) Randomized trial of vigabatrin in patients with infantile spasms. Neurology 57: 1416-1421.
6. Gaily E, Liukkonen E, Paetau R, Rekola M, Granström M-L,. (2001) Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Dev Med Child Neurol 43: 658-667.
7. Granström M-L, Gaily E, Liukkonen E,. (1999) Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms. Epilepsia 40: 950-957.
8. Hrachovy R, Frost J, Glaze D,. (1994) High-dose, long-duration corticotrophin therapy for infantile spasms. J Pediatr 124: 803-806.
9. Lux A, Edwards S, Hancock E, Johnson A, Kennedy C, Newton R, O'Callaghan F, Verity C, Osborne J,; on behalf of participating investigators. (2004) The United Kingdom infantile spasm study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomized controlled trial. Lancet 364: 1773-1778.
10. Lux A, Edwards S, Hancock E, Johnson A, Kennedy C, Newton R, O'Callaghan F, Verity C, Osborne J,; the trial steering committee on behalf of participating investigators. (2005) United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes at age 14 months: a multicentre randomised trial. Lancet Neurol 4: 712-717.
11. Parisi P, Bombardieri R, Curatolo P,. (2007) Current role of vigabatrin in infantile spasms. Review. Eur J Paediatr Neurol 11: 331-336.
12. Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, Gaillard WD, Gibson PA, Holmes GL, Nordli DR Jr, O'Dell C, Shields WD, Trevathan E, Wheless JW,. (2010) Infantile spasms: A U.S. consensus report. Epilepsia July 1 [Epub ahead of print].
13. Riikonen R,. (2001) ACTH therapy of West syndrome: Finnish views. Brain Dev 23: 642-646.
14. Riikonen R,. (2009) West syndrome. In, Nikanorova M, Genton P, Sabers A, (Eds) Long-term Evolution of Epileptic Encephalopathies. J Libbey, Esher, Surrey, UK, pp. 13-28.
15. Riikonen R, Jääskeläinen J, Turpeinen U,. (2010) Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms. Epilepsia doi:.
16. Vigevano P, Cilio R,. (1997) Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 38: 1270-1274.
17. Wheless J, Carmant L, Bebin M, Bebin M, Conry J, Chiron C, Elterman R, Frost M, Paolicchi J, Shields W, Thiele E, Zupanc M, Collins S, et al. (2009) Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 50: 195-205.
18. Willmore L, Abelson M, Ben-Menachem E, Pellock J, Shields W,. (2009) Vigabatrin: 2008 update. Critical review and invited commentary. Epilepsia 50: 163-173.
19. Yeh T, Lin Y, Lin H, Hwang C, Hsieh W, Lin C, Tsai C,. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304-1313. (Pubitemid 38375365)